Clinical Trials Browser

Lymphoma, B-Cell × Inotuzumab Ozogamicin × 90 days × Clear all

NCT05016947 2026-01-29

Venetoclax Plus Inotuzumab for B-ALL

Phase 1 Active not recruiting

Burkitt Lymphoma, Lymphoma, B-Cell